Dr. Olivier Jordan
Chief Executive Officer
He was trained in physical engineering at the Swiss Federal Institute of Technology Lausanne (EPFL) in Lausanne. During his PhD at Aebischer’s lab and later at the Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO) in Geneva, he became an expert in biomaterials for drug delivery. He owns nine patents, two of which are in the field of gel technology and have led to clinical applications. He has authored 65 peer-reviewed publications.
He graduated with an MSc in Finance and a BSc in Management from HEC Lausanne, University of Lausanne. He has experience in the corporate banking sector and has created a successful e-commerce business. Excited by digital transformation, he started in 2020 a BSc in Computer Science at the Swiss Federal Institute of Technology Lausanne (EPFL) in Lausanne. Bryan is in charge of the business development at KYLYS.
Prof. Eric Allémann
Chief Scientific Officer
He was trained in pharmaceutical sciences. Since 1990 he has been involved in nanomedicine formulation. After his PhD, a postdoc and several years as a research associate, Dr. Allémann joined Bracco Research as head of exploratory research. Since 2009 he is professor of Pharmaceutical Technology at ISPSO in Geneva. He is (co-)inventor of 13 international patents and has 100 publications.
He is a pharmacist and achieving a PhD in Pharmaceutical Technology at ISPSO in Geneva. He has been improving the synthesis and characterization of HA Pearls for more than two years. Since 2020, he is involved in the development of cosmetic brands.